These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
195 related articles for article (PubMed ID: 30557834)
1. MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer. Li J; Shao W; Feng H Biomed Pharmacother; 2019 Feb; 110():850-856. PubMed ID: 30557834 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y Cancer Lett; 2015 Jun; 362(1):122-30. PubMed ID: 25819031 [TBL] [Abstract][Full Text] [Related]
3. MicroRNA-127-3p acts as a tumor suppressor in epithelial ovarian cancer by regulating the BAG5 gene. Bi L; Yang Q; Yuan J; Miao Q; Duan L; Li F; Wang S Oncol Rep; 2016 Nov; 36(5):2563-2570. PubMed ID: 27571744 [TBL] [Abstract][Full Text] [Related]
4. Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p. Wang C; Qi S; Xie C; Li C; Wang P; Liu D J Gynecol Oncol; 2018 Nov; 29(6):e99. PubMed ID: 30207107 [TBL] [Abstract][Full Text] [Related]
5. MiR-539-3p promotes the progression of epithelial ovarian cancer by targeting SPARCL1. Gong YB; Fan XH Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2366-2373. PubMed ID: 30964161 [TBL] [Abstract][Full Text] [Related]
6. miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14. Ji Q; Xu X; Li L; Goodman SB; Bi W; Xu M; Xu Y; Fan Z; Maloney WJ; Ye Q; Wang Y Cell Death Dis; 2017 Oct; 8(10):e3103. PubMed ID: 29022909 [TBL] [Abstract][Full Text] [Related]
7. MiR-520a-3p inhibits malignant progression of epithelial ovarian cancer by targeting SUV39H1 expression. Li J; Shao W; Zhao J Hum Cell; 2021 Mar; 34(2):570-578. PubMed ID: 33196969 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-222-3p/GNAI2/AKT axis inhibits epithelial ovarian cancer cell growth and associates with good overall survival. Fu X; Li Y; Alvero A; Li J; Wu Q; Xiao Q; Peng Y; Hu Y; Li X; Yan W; Guo K; Zhou W; Wang Y; Liu J; Zhang Y; Mor G; Wen J; Yin G Oncotarget; 2016 Dec; 7(49):80633-80654. PubMed ID: 27811362 [TBL] [Abstract][Full Text] [Related]
9. miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway. Salem M; O'Brien JA; Bernaudo S; Shawer H; Ye G; Brkić J; Amleh A; Vanderhyden BC; Refky B; Yang BB; Krylov SN; Peng C Cancer Res; 2018 Aug; 78(15):4175-4190. PubMed ID: 29748371 [TBL] [Abstract][Full Text] [Related]
10. MiR-337-3p suppresses the proliferation and metastasis of clear cell renal cell carcinoma cells via modulating Capn4. Zhuang Q; Shen J; Chen Z; Zhang M; Fan M; Xue D; Lu H; Xu R; He X; Hou J Cancer Biomark; 2018; 23(4):515-525. PubMed ID: 30452399 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of Ovarian Epithelial Carcinoma Tumorigenesis and Progression by microRNA 106b Mediated through the RhoC Pathway. Chen S; Chen X; Xiu YL; Sun KX; Zhao Y PLoS One; 2015; 10(5):e0125714. PubMed ID: 25933027 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-135a-3p is downregulated and serves as a tumour suppressor in ovarian cancer by targeting CCR2. Duan S; Dong X; Hai J; Jiang J; Wang W; Yang J; Zhang W; Chen C Biomed Pharmacother; 2018 Nov; 107():712-720. PubMed ID: 30138893 [TBL] [Abstract][Full Text] [Related]
13. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression. Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143 [TBL] [Abstract][Full Text] [Related]
14. miR-205-3p Functions as a Tumor Suppressor in Ovarian Carcinoma. Qiao B; Wang Q; Zhao Y; Wu J Reprod Sci; 2020 Jan; 27(1):380-388. PubMed ID: 32046433 [TBL] [Abstract][Full Text] [Related]
15. miR-455 inhibits breast cancer cell proliferation through targeting CDK14. Wang B; Zou A; Ma L; Chen X; Wang L; Zeng X; Tan T Eur J Pharmacol; 2017 Jul; 807():138-143. PubMed ID: 28300591 [TBL] [Abstract][Full Text] [Related]
16. [The role of cyclin-dependent kinases in miR-193a5p regulating ovarian cancer cell proliferation and epithelial mesenchymal transformation]. Yang ZJ; DU XL Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Mar; 36(2):176-179. PubMed ID: 32744015 [No Abstract] [Full Text] [Related]
17. MiR-127-3p inhibits proliferation of ovarian cancer in rats through down-regulating MAPK4. Du SY; Huang XX; Li NM; Lv CY; Lv CH; Wei ML; Gao Z; Zhang YP Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10383-10390. PubMed ID: 33155194 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-613 impedes the proliferation and invasion of glioma cells by targeting cyclin-dependent kinase 14. Li Q; Zhou L; Wang M; Wang N; Li C; Wang J; Qi L Biomed Pharmacother; 2018 Feb; 98():636-642. PubMed ID: 29289838 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-299-3p suppresses proliferation and invasion by targeting VEGFA in human colon carcinoma. Wang JY; Jiang JB; Li Y; Wang YL; Dai Y Biomed Pharmacother; 2017 Sep; 93():1047-1054. PubMed ID: 28738498 [TBL] [Abstract][Full Text] [Related]
20. MiR-199a/b-3p inhibits gastric cancer cell proliferation via down-regulating PAK4/MEK/ERK signaling pathway. Zeng B; Shi W; Tan G BMC Cancer; 2018 Jan; 18(1):34. PubMed ID: 29304764 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]